Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital Tuebingen |
---|---|
Information provided by: | University Hospital Tuebingen |
ClinicalTrials.gov Identifier: | NCT00289445 |
The aim of this study was to define the maximum tolerated dose (MTD) of bolus mitomycin C (MMC) in combination with 24 h-continuous infusion of 5-fluorouracil (FU) plus folinic acid, and to assess the toxicity and activity in patients with previously treated colorectal and gastric cancer.
Escalating doses of MMC starting from 6 mg m(-2) in 2 mg m(-2)-steps to a maximum of 10 mg m(-2) were applied on days 1 and 22, given to fixed doses of 5-FU (2.600 mg m(-2)) as 24 h infusion and folinic acid 500 mg m(-2) prior to 5-FU weekly for 6 weeks
Condition | Intervention | Phase |
---|---|---|
Gastrointestinal Neoplasms Neoplasm Metastasis |
Drug: Mitomycin C Drug: 5-FU Drug: Folinic acid |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Open, Multi-Center Phase I/II Trial With Mitomycin C in Combination With 5-Fluorouracil and Folinic Acid in Pretreated Patients With Metastatic Gastrointestinal Cancer |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Phase 1 (dose escalation)
Exclusion Criteria:
Principal Investigator: | Carsten Bokemeyer, MD | University Hospital Tuebingen (PI until 30Nov2004) |
Principal Investigator: | Joerg T Hartmann, MD | University Hospital Tuebingen |
Study ID Numbers: | jth_003 |
Study First Received: | February 8, 2006 |
Last Updated: | April 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00289445 History of Changes |
Health Authority: | Germany: Regierungspräsidium Tübingen (federal level) |
Vitamin B Complex Digestive System Neoplasms Hematinics Gastrointestinal Diseases Leucovorin Trace Elements Mitomycins Folic Acid Anti-Bacterial Agents |
Digestive System Diseases Fluorouracil Vitamins Mitomycin Neoplasm Metastasis Gastrointestinal Neoplasms Micronutrients Alkylating Agents |
Molecular Mechanisms of Pharmacological Action Gastrointestinal Diseases Antineoplastic Agents Hematologic Agents Physiological Effects of Drugs Leucovorin Antibiotics, Antineoplastic Mitomycins Neoplastic Processes Pathologic Processes Neoplasms by Site Therapeutic Uses Vitamins Mitomycin |
Neoplasm Metastasis Micronutrients Alkylating Agents Nucleic Acid Synthesis Inhibitors Digestive System Neoplasms Vitamin B Complex Hematinics Growth Substances Enzyme Inhibitors Pharmacologic Actions Folic Acid Neoplasms Digestive System Diseases Gastrointestinal Neoplasms |